Balance between proinflammatory cytokines and their inhibitors in bronchial lavage from patients with status asthmaticus

American Journal of Respiratory and Critical Care Medicine

Volumn 159, Issue 2, 1999, Pages 487-494

  Tillie Leblond, Isabelle ^b   Pugin, Jérôme ^b   Marquette, Charles Hugo ^b   Lamblin, Catherine ^b   Saulnier, Fabienne ^b   Brichet, Anne ^b   Wallaert, Benoit ^b   Tonnel, André Bernard ^a   Gosset, Philippe ^b  

^a INSTITUT PASTEUR DE LILLE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR;

ADULT; ARTICLE; ASTHMATIC STATE; BRONCHOSPASM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATION; MALE; NEUTROPHIL; PRIORITY JOURNAL; RESPIRATORY FAILURE;

EID: 0008249094     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.159.2.9805115     Document Type: Article

References (40)

1. Jeffery, P. K., A. J. Wardlaw, F. C. Nelson, J. V. Collins, and A. B. Kay. 1989. Bronchial biopsies in asthma. Am. Rev. Respir. Dis. 140:1745-1753.
2. Laitinen, L. A., M. Heino, A. Laitinen, T. Kawa, and T. Haathela. 1985. Damage of the airway epithelium and bronchial reactivity in patients with asthma. Am. Rev. Respir. Dis. 121:599-606.
3. Beasley, R., W. R. Roche, J. A. Roberts, and S. T. Holgate. 1989. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am. Rev. Respir. Dis. 139:806-817.
4. Bradding, P. J., J. A. Roberts, K. M. Britten, S. Montefort, R. Djukanovic, R. Mueller, C. H. Heusser, P. H. Howarth, and S. T. Holgate. 1994. Interleukin-4, 5 and 6 and tumor necrosis factor alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines. Am. J. Respir. Cell Mol. Biol. 10:471-480.
5. Gosset, P., A. Tsicopoulos, B. Wallaert, C. Vanimmenus, M. Joseph, A. B. Tonnel, and A. Capron. 1991. Increased secretion of tumour necrosis factor a and interleukin-6 by alveolar macrophages consecutive to the development of the late asthmatic reaction. J. Allergy Clin. Immunol. 88:561-572.
6. Pujol, J. L., B. Cosso, J. P. Daures, J. Clot, F. B. Michel, and P. Godard. 1990. Interleukin-1 secretion by alveolar macrophages from patients with bronchial asthma. Int. Arch. Allergy Appl. Immunol. 91:207-210.
7. Gosset, P. Lassalle, A. B. Tonnel, B. Wallaert, L. Prin, J. Pestel, and A. Capron. 1988. Production of an IL-1 inhibitory factor by alveolar macrophages in allergic asthma. Am. Rev. Respir. Dis. 138:40-46.
8. Sim, T. C., K. A. Hilsmeier, L. M. Reece, J. A. Grant, and R. Alam. 1994. Interleukin-1 receptor antagonist protein inhibits the synthesis of IgE and proinflammatory cytokines by allergen-stimulated mononuclear cells. Am. J. Respir. Cell Mol. Biol. 11:473-479.
9. Zuany-Amorim, C., S. Haile, D. Leduc, C. Dumarey, M. Huerre, B. B. Vargaftig, and M. Pretolani. 1995. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitized mice. J. Clin. Invest. 95:2644-2651.
10. Swain, S. L., G. Huston, S. Tonkonogy, and A. Weinberg. 1991. Transforming growth factor β and interleukin-4 cause helper T cell precursors to develop into distinct effector helper cells that differ in lymphokine secretion pattern and cell surface phenotype. J. Immunol. 147:2991-3000.
11. Messer, J. W., G. A. Peters, and W. A. Bennett. 1960. Causes of death and pathologic findings in 304 cases of bronchial asthma. Dis. Chest 39:616-620.
12. Cardell, B. S., and R. S. B. Pearson. 1959. Death in asthmatics. Thorax 14:341-352.
13. Houston, J. C., S. De Navasquez, and J. R. Trounce. 1953. A clinical and pathological study of fatal cases of status asthmaticus. Thorax 8:207-213.
14. Carroll, N., J. Elliot, A. Morton, and A. James. 1993. The structure of large and small airways in nonfatal and fatal asthma. Am. Rev. Respir. Dis. 147:405-410.
15. Carroll, N., S. Carello, C. Cooke, and A. James. 1996. Airway structure and inflammatory cells in fatal attacks of asthma. Eur. Respir. J. 9:709-715.
16. Sur, S., T. B. Crotty, G. M. Kephart, B. A. Hyma, T. V. Colby, C. E. Reed, L. W. Hunt, and G. J. Gleich. 1993. Sudden-onset fatal asthma: distinct entity with few neutrophils and relatively more neutrophils in the airway submucosa? Am. Rev. Respir. Dis. 148:713-719.
17. Azzawi, M., P. W. Johnston, S. Majumdar, A. B. Kay, and P. K. Jeffery. 1992. T Lymphocytes and activated eosinophils in airway mucosa in fatal asthma and cystic fibrosis. Am. Rev. Respir. Dis. 145:1477-1482.
18. Wasserfallen, J.-B., M. D. Schaller, F. Feihl, and C. H. Perret. 1990. Sudden asphyxic asthma: a distinct entity? Am. Rev. Respir. Dis. 142:108- 111.
19. Reid, L. M. 1987. The presence or absence of bronchial mucus in fatal asthma. J. Allergy Clin. Immunol. 80:415-416.
20. Fahy, J. V., K. W. Kim, J. Liu, and H. A. Boushey. 1995. Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. J. Allergy Clin. Immunol. 95:843-852.
21. American Thoracic Society. 1987. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 136:225-244.
22. Lang, L. M., R. A. Simon, D. A. Mathison, R. M. Timms, and D. D. Stevenson. 1991. Biopsy and possible efficacy of fiberoptic bronchoscopy with lavage in the management of refractory asthma with mucous impaction. Ann. Allergy 67:324-330.
23. Lamblin, C., P. Gosset, I. Tillie-Leblond, F. Saulnier, C. H. Marquette, B. Wallaert, and A. B. Tonnel. 1998. Bronchial neutrophilia in patients with noninfectious status asthmaticus. Am. J. Respir. Crit. Care Med. 157:394-402.
24. Broide, D. H., M. Lotz, A. J. Cuomo, D. A. Coburn, E. C. Federman, and S. I. Wasserman. 1992. Cytokines in symptomatic asthma airways. J. Allergy Clin. Immunol. 89:958-967.
25. Aas, K. 1981. Heterogeneity of bronchial asthma: subpopulations or different stages of the disease. Allergy 36:3-10.
26. Pugin, J., B. Ricou, K. P. Steinberg, P. M. Suter, and T. R. Martin. 1996. Pro-inflammatory activity in bronchoalveolar lavage fluids from patients with ARDS, a prominent role for interleukin-1. Am. J. Respir. Crit. Care Med. 153:1850-1856.
27. Bochner, B. S., F. W. Luscinskas, M. A. Gimbrone, W. Newman, S. A. Sterbinsky, C. P. Derse-Anthony, D. Klunk, and R. P. Schleimer. 1991. Adhesion of human basophils, eosinophils, and neutrophils to interleukin 1-activated human vascular endothelial cells: contributions of endothelial cell adhesion molecules. J. Exp. Med. 173:1553-1557.
28. Broudy, V. C., K. Kaushansky, G. M. Segal, J. M. Harlan, and J. W. Adamson. 1986. Tumor necrosis factor type α stimulates human endothelial cells to produce granulocyte/macrophage colony-stimulating factor. Proc. Natl. Acad. Sci. U.S.A. 83:7467-7471.
29. Kips, J. C., J. Tavernier, and R. A. Pauwels. 1992. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. J. Respir. Crit. Care Med. 145:332-336.
30. Thomas, P. S., D. H.Yates, and P. J. Barnes. 1995. Tumor necrosis factor α increases airway responsiveness and sputum neutrophilia in normal human subjects. Am. J. Respir. Crit. Care Med. 152:76-80.
31. Watson, M. L., D. Smith, A. D. Bourne, R. C. Thompson, and J. Westwick. 1993. Cytokines contribute to airway dysfunction in antigen-challenged guinea pigs: inhibition of airway hyperreactivity, pulmonary eosinophil accumulation and tumor necrosis factor generation by pretreatment with an interleukin-1 receptor antagonist. Am. J. Respir. Cell Mol. Biol. 8:365-369.
32. Slungaard, A., G. M. Vercellotti, G. Walker, R. D. Nelson, and H. S. Jacob. 1990. Tumor necrosis factor α/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium. J. Exp. Med. 171:2025-2041.
33. Standiford, T. J., S. L. Kunkel, M. A. Basha, S. W. Chensue, J. P. Lynch, G. B. Toews, J. Westwick, and R. M. Strieter. 1990. Interleukin-8 gene expression by a pulmonary epithelial cell line. J. Clin. Invest. 86:1945- 1953.
34. Hirano, T., S. Akira, T. Taga, and T. Kishimoto. 1990. Biological and clinical aspects of interleukin-6. Immunol. Today 11:443-449.
35. Tilg, H., E. Treh, M. B. Atkins, C. A. Dinarello, and J. W. Mier. 1994. Interleukin-6 as an anti-inflammatory cytokine: induction of circulating interleukin-1 receptor antagonist and soluble tumor necrosis factor receptor p 55. Blood 83:113-118.
36. Marini, M., E. Vittori, S. Hollemborg, and S. Mattoli. 1992. Expression of the potent inflammatory cytokines, granulocyte-macrophage-colony stimulating factor and interleukin-1 and interleukin-8 in bronchial epithelial cells of patients with asthma. J. Allergy Clin. Immumol. 89:1001-1009.
37. Martin, T. R. 1997. Cytokines and the acute respiratory distress syndrome (ARDS): a question of balance. Nat. Med. 3:272-273.
38. Fischer, E., K. J. Van Zee, M. A. Marano, C. S. Rock, J. S. Kenney, D. D. Poutsiaka, C. A. Dinarello, S. F. Lowry, and L. L. Moldarwer. 1992. Interleukin-1 receptor antagonist circulates in experimental inflammation and in human disease. Blood 79:2196-2200.
39. Shull, M. M., I. Ormsby, A. B. Kier, S. Pawlowski, R. J. Diebold, M. Yin, K. Allen, C. Sidman, G. Proetzel, D. Calvin, N. Annuziata, and T. Doetschman. 1992. Targeted disruption of the mouse transforming growth factor β1 gene results in multifocal inflammatory disease. Nature 359:693-699.
40. Dreyfuss, D., and G. Saumon. 1998. Ventilator-induced lung injury: lessons from experimental studies. Am. J. Respir. Crit. Care Med. 157:294-323.